These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 9845542)

  • 1. Lineage involvement of stem cells bearing the philadelphia chromosome in chronic myeloid leukemia in the chronic phase as shown by a combination of fluorescence-activated cell sorting and fluorescence in situ hybridization.
    Takahashi N; Miura I; Saitoh K; Miura AB
    Blood; 1998 Dec; 92(12):4758-63. PubMed ID: 9845542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Progress in laboratory medicine in chronic myeloid leukemia].
    Miura A
    Rinsho Byori; 1998 Dec; 46(12):1226-31. PubMed ID: 9916508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cytogenetics of stem cells: target cells of chromosome aberrations as revealed by the application of fluorescence in situ hybridization to fluorescence-activated cell sorting.
    Miura I; Takahashi N; Kobayashi Y; Saito K; Miura AB
    Int J Hematol; 2000 Oct; 72(3):310-7. PubMed ID: 11185986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ph-negative non-Hodgkin's lymphoma occurring in chronic phase of Ph-positive chronic myelogenous leukemia is defined as a genetically different neoplasm from extramedullary localized blast crisis: report of two cases and review of the literature.
    Ichinohasama R; Miura I; Takahashi N; Sugawara T; Tamate E; Endoh K; Endoh F; Naganuma H; DeCoteau JF; Griffin JD; Kadin ME; Ooya K
    Leukemia; 2000 Jan; 14(1):169-82. PubMed ID: 10637493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous demonstration of the Philadelphia chromosome in T, B, and myeloid cells.
    MacKinney AA; Clark SS; Borcherding W; Fizzotti M; Hong R
    Am J Hematol; 1993 Sep; 44(1):48-52. PubMed ID: 7688179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukemic burden in subpopulations of CD34+ cells isolated from the mobilized peripheral blood of alpha-interferon-resistant or -intolerant patients with chronic myeloid leukemia.
    Van den Berg D; Wessman M; Murray L; Tong J; Chen B; Chen S; Simonetti D; King J; Yamasaki G; DiGiusto R; Gearing D; Reading C
    Blood; 1996 May; 87(10):4348-57. PubMed ID: 8639795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients.
    Verfaillie CM; Bhatia R; Miller W; Mortari F; Roy V; Burger S; McCullough J; Stieglbauer K; Dewald G; Heimfeld S; Miller JS; McGlave PB
    Blood; 1996 Jun; 87(11):4770-9. PubMed ID: 8639848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation at single cell level of residual Philadelphia negative hemopoietic stem cells in chronic phase CML patients.
    Akel S; Kolialexi A; Mavrou A; Metaxotou C; Loukopoulos D; Yataganas X
    Cancer Genet Cytogenet; 2000 Oct; 122(2):93-100. PubMed ID: 11106818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Megakaryocytes carry the fused bcr-abl gene in chronic myeloid leukaemia: a fluorescence in situ hybridization analysis from bone marrow biopsies.
    Nolte M; Werner M; Ewig M; von Wasielewski R; Link H; Diedrich H; Georgii A
    Virchows Arch; 1996 Mar; 427(6):561-5. PubMed ID: 8605566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The generation of human natural killer cells from CD34+/DR- primitive progenitors in long-term bone marrow culture.
    Miller JS; Verfaillie C; McGlave P
    Blood; 1992 Nov; 80(9):2182-7. PubMed ID: 1384796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The generation of immunocompetent dendritic cells from CD34+ acute myeloid or lymphoid leukemia cells.
    Tsuchiya T; Hagihara M; Shimakura Y; Ueda Y; Gansuvd B; Munkhbat B; Inoue H; Tazume K; Kato S; Hotta T
    Int J Hematol; 2002 Jan; 75(1):55-62. PubMed ID: 11843292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lineage involvement in chronic myeloid leukaemia: comparison between MBCR/ABL and mBCR/ABL cases.
    Primo D; Sanchez ML; Espinosa AB; Tabernero MD; Rasillo A; Sayagués JM; Gonzalez M; Hernandez JM; Orfao A
    Br J Haematol; 2006 Mar; 132(6):736-9. PubMed ID: 16487173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expansion of Philadelphia chromosome-negative CD3(+)CD56(+) cytotoxic cells from chronic myeloid leukemia patients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice.
    Hoyle C; Bangs CD; Chang P; Kamel O; Mehta B; Negrin RS
    Blood; 1998 Nov; 92(9):3318-27. PubMed ID: 9787169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of residual CD34(+) Ph(+) progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first-line nilotinib therapy.
    Defina M; Ippoliti M; Gozzetti A; Abruzzese E; Castagnetti F; Crupi R; Tiribelli M; Breccia M; Salvucci M; Aprile L; Baratè C; Gozzini A; Rosti G; Lauria F; Bocchia M
    Cancer; 2012 Nov; 118(21):5265-9. PubMed ID: 22517301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCR/ABL-negative progenitors are enriched in the adherent fraction of CD34+ cells circulating in the blood of chronic phase chronic myeloid leukemia patients.
    Grand FH; Marley SB; Chase A; Titley I; Healy L; Spencer A; Reiter A; Goldman JM; Gordon MY
    Leukemia; 1997 Sep; 11(9):1486-92. PubMed ID: 9305602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The BCR/ABL transgene causes abnormal NK cell differentiation and can be found in circulating NK cells of advanced phase chronic myelogenous leukemia patients.
    Nakajima H; Zhao R; Lund TC; Ward J; Dolan M; Hirsch B; Miller JS
    J Immunol; 2002 Jan; 168(2):643-50. PubMed ID: 11777957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence in situ hybridization of progenitor cells obtained by fluorescence-activated cell sorting for the detection of cells affected by chromosome abnormality trisomy 8 in patients with myelodysplastic syndromes.
    Saitoh K; Miura I; Takahashi N; Miura AB
    Blood; 1998 Oct; 92(8):2886-92. PubMed ID: 9763574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCR/ABL- CD34(+)HLA-DR- progenitor cells in early chronic phase, but not in more advanced phases, of chronic myelogenous leukemia are polyclonal.
    Delforge M; Boogaerts MA; McGlave PB; Verfaillie CM
    Blood; 1999 Jan; 93(1):284-92. PubMed ID: 9864172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ontogeny of natural killer cells and T cells by analysis of BCR-ABL rearrangement from patients with chronic myelogenous leukaemia.
    Cho EK; Heo DS; Seol JG; Seo EJ; Chi HS; Kim ES; Lee YY; Kim BK; Kim NK
    Br J Haematol; 2000 Oct; 111(1):216-22. PubMed ID: 11091204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow derived mesenchymal stem cells from chronic myeloid leukemia t(9;22) patients are devoid of Philadelphia chromosome and support cord blood stem cell expansion.
    Jootar S; Pornprasertsud N; Petvises S; Rerkamnuaychoke B; Disthabanchong S; Pakakasama S; Ungkanont A; Hongeng S
    Leuk Res; 2006 Dec; 30(12):1493-8. PubMed ID: 16839603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.